Last reviewed · How we verify

NCT06973616

A Clinical Trial of Two Types of Aesthetics Crowns for Primary Molars

ENROLLING BY INVITATION NA Last updated 15 May 2025
What this trial tests

NA trial testing Zirconia crown in Success Rate in 85 participants. Enrolling by invitation.

Timeline
2 January 2024
Primary endpoint
30 December 2025
30 December 2026

Quick facts

Lead sponsorKing Abdullah University Hospital
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment85
Start date2 January 2024
Primary completion30 December 2025
Estimated completion30 December 2026
Sites1 location across Jordan

Drugs / interventions tested

Conditions studied

Sponsor

King Abdullah University Hospital

Who can join

Adults 4 to 10, any sex, with Success Rate. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Currently, prefabricated zirconia crowns have been used as an aesthetic restorative material for primary teeth for a few years. Another recently introduced esthetic crown is the Bioflx™ crown. It is made of a resin polymer and claimed to have high strength , flexibility and durability. The aim of this study is to evaluate and compare the clinical and radiographic success of zirconia crowns to that of Bioflx™ crowns in carious primary molars.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Zirconia crown

Trials testing the same drug.

Other recruiting trials for Success Rate

Currently open trials in the same condition.

Other King Abdullah University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06973616.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing